| dc.contributor.author | Tomasik, Jakub | |
| dc.contributor.author | Lago, Santiago G. | |
| dc.contributor.author | Vázquez Bourgon, Javier | |
| dc.contributor.author | Papiol, Sergi | |
| dc.contributor.author | Suárez Pinilla, Paula | |
| dc.contributor.author | Crespo Facorro, Benedicto | |
| dc.contributor.author | Bahn, Sabine | |
| dc.contributor.other | Universidad de Cantabria | es_ES |
| dc.date.accessioned | 2020-07-15T17:17:07Z | |
| dc.date.available | 2020-07-15T17:17:07Z | |
| dc.date.issued | 2019-04 | |
| dc.identifier.issn | 2168-622X | |
| dc.identifier.issn | 2168-6238 | |
| dc.identifier.uri | http://hdl.handle.net/10902/18916 | |
| dc.description.abstract | This study examines the association between insulin resistance, schizophrenia polygenic risk, and treatment outcomes in first-episode, antipsychotic-naive patients with schizophrenia. | es_ES |
| dc.description.sponsorship | Funding/Support: This work was supported by grants from the Stanley Medical Research Institute (Dr Bahn). | es_ES |
| dc.format.extent | 10 p. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | American Medical Association (AMA) | es_ES |
| dc.rights | © American Medical Association (AMA) | es_ES |
| dc.source | JAMA Psychiatry
. 2019 Apr 3;76(8):864-867 | es_ES |
| dc.title | Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic Treatment | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publisherVersion | https://www.doi.org/10.1001/jamapsychiatry.2019.0304 | es_ES |
| dc.rights.accessRights | openAccess | es_ES |
| dc.identifier.DOI | 10.1001/jamapsychiatry.2019.0304 | |
| dc.type.version | publishedVersion | es_ES |
